中国结直肠癌卵巢转移诊疗专家共识(2020版)

2020-04-30 中国医师协会结直肠肿瘤专委会 中华结直肠疾病电子杂志.2020,9(2):115-121.

我国结直肠癌发病率和死亡率位于恶性肿瘤前五位。卵巢转移作为女性结直肠肿瘤患者相对少见的转移部位,其症状隐匿、进展迅速,对于常规化疗敏感性欠佳,临床治疗选择存在争议。因此,在中国医师协会结直肠肿瘤专业委

中文标题:

中国结直肠癌卵巢转移诊疗专家共识(2020版)

发布日期:

2020-04-30

简要介绍:

我国结直肠癌发病率和死亡率位于恶性肿瘤前五位。卵巢转移作为女性结直肠肿瘤患者相对少见的转移部位,其症状隐匿、进展迅速,对于常规化疗敏感性欠佳,临床治疗选择存在争议。因此,在中国医师协会结直肠肿瘤专业委员会的组织下,国内相关领域权威专家共同制定《中国结直肠癌卵巢转移诊疗专家共识》,以规范结直肠癌卵巢转移患者的诊疗流程,从而提高我国结直肠肿瘤的整体诊治水平,延长结直肠癌患者生存时间,改善生活质量。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=906006, encodeId=6066906006cc, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Tue Dec 08 14:49:28 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899330, encodeId=91c2899330e2, content=很值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff671406411, createdName=252228029, createdTime=Sun Nov 15 16:00:10 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881843, encodeId=6c088818437d, content=正好用的上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqVLyH0af253KFLobLLJBBkIqsYsV3zYP9ibMDFJJc4DEJohomeEBib1emvGQ3cG47B6HnEhIvawbx/0, createdBy=28c11924642, createdName=深海一只鱼, createdTime=Tue Sep 01 19:00:24 CST 2020, time=2020-09-01, status=1, ipAttribution=)]
    2020-12-08 14861974m47(暂无昵称)

    👍👍👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=906006, encodeId=6066906006cc, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Tue Dec 08 14:49:28 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899330, encodeId=91c2899330e2, content=很值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff671406411, createdName=252228029, createdTime=Sun Nov 15 16:00:10 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881843, encodeId=6c088818437d, content=正好用的上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqVLyH0af253KFLobLLJBBkIqsYsV3zYP9ibMDFJJc4DEJohomeEBib1emvGQ3cG47B6HnEhIvawbx/0, createdBy=28c11924642, createdName=深海一只鱼, createdTime=Tue Sep 01 19:00:24 CST 2020, time=2020-09-01, status=1, ipAttribution=)]
    2020-11-15 252228029

    很值得学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=906006, encodeId=6066906006cc, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Tue Dec 08 14:49:28 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899330, encodeId=91c2899330e2, content=很值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff671406411, createdName=252228029, createdTime=Sun Nov 15 16:00:10 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881843, encodeId=6c088818437d, content=正好用的上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqVLyH0af253KFLobLLJBBkIqsYsV3zYP9ibMDFJJc4DEJohomeEBib1emvGQ3cG47B6HnEhIvawbx/0, createdBy=28c11924642, createdName=深海一只鱼, createdTime=Tue Sep 01 19:00:24 CST 2020, time=2020-09-01, status=1, ipAttribution=)]
    2020-09-01 深海一只鱼

    正好用的上

    0

拓展阅读

2010 BSG 中高危人群结直肠癌筛查与监测指南

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2010-05-01

2010 结直肠癌肝转移诊断和综合治疗指南(V 2010)

中华医学会外科学分会 · 2010-06-01

2011 NICE 结直肠癌诊疗指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011NICE 结直肠癌高危人群(溃疡性结肠炎、克罗恩病、结直肠腺瘤患者)结肠镜监测指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-03-23

2011 规范结直肠癌术中缓释型氟尿嘧啶腹腔内化疗的专家共识

结直肠癌术中缓释型氟尿嘧啶腹腔内化疗共识专家组 · 2011-06-01

结直肠癌诊疗规范(2010年版)

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-12-20